Teladoc Health (NYSE:TDOC) PT Lowered to $10.00

Teladoc Health (NYSE:TDOC) had its price target cut by research analysts at Barclays from $20.00 to $10.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the health services provider’s stock. Barclays‘s price target would suggest a potential upside of 12.61% from the company’s current price.

A number of other brokerages also recently issued reports on TDOC. Wells Fargo & Company cut their price objective on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Monday, April 29th. Royal Bank of Canada cut their price objective on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, April 26th. TD Cowen cut their price objective on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research report on Friday, April 26th. Canaccord Genuity Group cut their price objective on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Evercore ISI cut their price objective on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Thirteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $15.53.

Teladoc Health Stock Down 5.8 %

NYSE TDOC traded down $0.55 during trading on Thursday, reaching $8.88. 11,978,203 shares of the company’s stock traded hands, compared to its average volume of 5,380,381. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of -6.30 and a beta of 0.94. The company’s 50 day simple moving average is $10.06 and its two-hundred day simple moving average is $13.85. Teladoc Health has a 12-month low of $8.13 and a 12-month high of $27.36.

Insider Activity at Teladoc Health

In related news, Director Karen L. Daniel sold 9,834 shares of the business’s stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the transaction, the director now directly owns 36,995 shares in the company, valued at approximately $440,240.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders sold a total of 15,388 shares of company stock worth $178,225 in the last three months. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. Oak Thistle LLC purchased a new stake in Teladoc Health in the 4th quarter worth $537,000. International Assets Investment Management LLC increased its holdings in Teladoc Health by 1,777.0% in the 4th quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider’s stock worth $2,414,000 after acquiring an additional 106,069 shares in the last quarter. Sowell Financial Services LLC increased its holdings in Teladoc Health by 40.8% in the 4th quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock worth $407,000 after acquiring an additional 5,475 shares in the last quarter. Lecap Asset Management Ltd. purchased a new stake in Teladoc Health in the 4th quarter worth $1,530,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Teladoc Health by 15.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 56,181 shares of the health services provider’s stock worth $1,211,000 after acquiring an additional 7,583 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.